The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?
about
Molecular Pathways Regulating Macrovascular Pathology and Vascular Smooth Muscle Cells Phenotype in Type 2 DiabetesImplications of autophagy for vascular smooth muscle cell function and plasticitySalidroside inhibits high-glucose induced proliferation of vascular smooth muscle cells via inhibiting mitochondrial fission and oxidative stressResveratrol protects vascular smooth muscle cells against high glucose-induced oxidative stress and cell proliferation in vitro.Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function.Alteration of mevalonate pathway in proliferated vascular smooth muscle from diabetic mice: possible role in high-glucose-induced atherogenic process.Reduced vascular responses to soluble guanylyl cyclase but increased sensitivity to sildenafil in female rats with type 2 diabetes.SGLT inhibitors attenuate NO-dependent vascular relaxation in the pulmonary artery but not in the coronary artery.Endurance, interval sprint, and resistance exercise training: impact on microvascular dysfunction in type 2 diabetesAugmented dilation to nitric oxide in uterine arteries from rats with type 2 diabetes: implications for vascular adaptations to pregnancy.Insulin resistance and hyperglycaemia in cardiovascular disease development.Epigenetics in the development, modification, and prevention of cardiovascular disease.Vascular Smooth Muscle as a Target for Novel Therapeutics.Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney DiseaseInhibition of TLR4 attenuates vascular dysfunction and oxidative stress in diabetic rats.Human induced pluripotent stem cell-derived vascular smooth muscle cells: differentiation and therapeutic potential.Relationship between PDK1 and contraction in carotid arteries in Goto-Kakizaki rat, a spontaneous type 2 diabetic animal model.Activation of Macrophages and Microglia by Interferon-γ and Lipopolysaccharide Increases Methylglyoxal Production: A New Mechanism in the Development of Vascular Complications and Cognitive Decline in Type 2 Diabetes Mellitus?Insulin augments serotonin-induced contraction via activation of the IR/PI3K/PDK1 pathway in the rat carotid artery.Diabetic retinopathy and endothelin system: microangiopathy versus endothelial dysfunction.
P2860
Q26782445-AAC66237-2382-48B9-804A-F39E98FF6E98Q26863422-41E6F1B7-AB29-4B75-8DC9-9B282A8FD9A6Q33846848-CB5911B7-E3D4-418F-9850-A703567EFAFAQ33893097-DC9BE8F7-D6D8-45D5-9F50-EC689E94EC2BQ34001116-467C4E3E-BDF8-4ABA-BF21-0F566AEA49D1Q35415550-4E5BEE64-E3A3-44C9-B9F8-FA54B55A6CC0Q35859307-8C149873-196D-4A81-BA14-97259BDEFF52Q36237217-B623EBA1-40E7-42BE-A19C-E495608840BFQ36699611-CB4E0963-7BAF-4009-A309-EC6DDA18AC71Q37576136-094433DA-F746-44A5-A340-643F05723551Q38198953-0AAAD700-EF80-47E7-BE32-8C8304D3A4F0Q38247712-7E449E9F-25B7-4844-A9E6-3D034F64852CQ38567506-0C555720-9070-4312-9AE6-171974DF3311Q41452150-DAA644D1-4F5C-4709-B0BC-EDD376DAAFB6Q46699315-47C0CF5A-C2E9-4FCA-AD79-C2B6EEA7BD17Q50243876-5463A85C-38E2-45A1-A94C-6E6C0D605F10Q50935134-4304B4BF-A51A-4FA0-B20B-0378C41E1BF4Q53244774-7953A338-F69F-4E9A-B551-F2AD9F6AD4B8Q53274334-19F248B9-3305-4A2B-8595-A8B97F53E4C4Q55643991-2ECFD4AF-6AF3-4CFB-82D2-1E23803264E0
P2860
The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?
@en
The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?
@en-gb
type
label
The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?
@en
The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?
@en-gb
prefLabel
The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?
@en
The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?
@en-gb
P2860
P356
P1154
2-s2.0-84878104687
P1433
P1476
The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?
@en
P2860
P304
P356
10.1042/CS20120413
P407
P577
2013-08-01T00:00:00Z